ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05200	Pathways in cancer	7/29	492/7206	0.00276277434424
ko03008	Ribosome biogenesis in eukaryotes	3/29	79/7206	0.00377444786894
ko00900	Terpenoid backbone biosynthesis	2/29	24/7206	0.00408589399901
ko05220	Chronic myeloid leukemia	3/29	85/7206	0.00463870025896
ko05224	Breast cancer	4/29	174/7206	0.00486625047041
ko05206	MicroRNAs in cancer	4/29	177/7206	0.00517048284053
ko04012	ErbB signaling pathway	3/29	109/7206	0.00924286792212
ko00261	Monobactam biosynthesis	1/29	3/7206	0.0120264118577
ko05223	Non-small cell lung cancer	2/29	66/7206	0.0286148453038
ko05217	Basal cell carcinoma	2/29	68/7206	0.0302395609664
ko04910	Insulin signaling pathway	3/29	172/7206	0.0309900062139
ko04150	mTOR signaling pathway	3/29	184/7206	0.0367853299501
ko04390	Hippo signaling pathway	3/29	188/7206	0.0388340573595
ko00920	Sulfur metabolism	1/29	10/7206	0.0395474451342
ko05214	Glioma	2/29	79/7206	0.0398059843105
ko03018	RNA degradation	2/29	84/7206	0.0444883517656
ko05218	Melanoma	2/29	85/7206	0.0454485843327
ko05169	Epstein-Barr virus infection	3/29	206/7206	0.0487667375859